FMP
Sep 15, 2025 11:12 PM - Alex Lavoie(Last modified: Sep 16, 2025 1:08 PM)
Image credit: Google Images
Chubb Limited (NYSE:CB) is a leading global insurance company offering a diverse range of insurance products, including property and casualty, accident and health, reinsurance, and life insurance. Competing with giants like AIG and Travelers, Chubb stands out as one of the largest publicly traded property and casualty companies in the market.
On September 15, 2025, Tracy Benguigui from Wolfe Research set a bullish price target of $320 for Chubb, suggesting a potential upside of 16.65% from its then-current trading price of $274.33. This optimistic outlook reflects confidence in Chubb's future performance and growth potential.
In a recent trading session, Chubb's stock demonstrated resilience and growth, closing at $283.19, a 2.07% increase from the previous day. This performance notably surpassed the gains of major indexes, including the S&P 500, the Dow, and the Nasdaq, as reported by Zacks. However, over the past month, Chubb's stock has seen a modest rise of 0.88%, trailing behind the Finance sector's gain of 2.7% and the S&P 500's gain of 2.38%.
Investors are keenly awaiting Chubb's upcoming earnings report, with analysts setting expectations for earnings of $5.39 per share, which would mark a year-over-year decline of 5.77%. Despite this anticipated dip in earnings, the Zacks Consensus Estimate for net sales stands at $15.87 billion, reflecting a 5.73% increase from the previous year. For the full fiscal year, earnings are projected at $21.57 per share with revenue expectations of $59.41 billion.
Currently, Chubb's stock price is $274.33, experiencing a decrease of 1.36% or $3.78. The stock has fluctuated between $273.56 and $277.92 in today's trading session. Over the past year, Chubb has reached a high of $306.91 and a low of $252.16. The company boasts a market capitalization of approximately $109.37 billion, with a trading volume of 2,418,144 shares on the NYSE.
Allstate Corporation (NYSE:ALL) is a prominent player in the insurance industry, offering a wide range of products inclu...
Champions Oncology, Inc. (NASDAQ: CSBR) is a key player in the field of translational oncology research. The company foc...